Cheche COO reports stock and option holdings
Cheche Group Inc. filed an initial Form 3 showing that Chief Operating Officer Liu Yanjun Jayla holds Class A common stock, restricted stock and multiple stock option awards.
Rhea-AI Filing Summary
Cheche Group Inc. filed an initial Form 3 showing that Chief Operating Officer Liu Yanjun Jayla holds Class A common stock, restricted stock and multiple stock option awards. The options allow purchases of Class A common stock at an exercise price of $0.1000 per share, with expirations between 2033 and 2035.
Footnotes explain grants under the 2019 and 2023 Equity Incentive Plans, including a 36,800‑share option grant on December 31, 2023 and additional grants of 20,000, 10,000, and 350 options on various 2024–2025 dates. Earlier restricted stock grants are fully vested but remain subject to transfer restrictions that lapse 30 months after the company’s IPO date.
Positive
- None.
Negative
- None.
Insider Trade Summary
8 transactions reported
Mixed
8 txns
Insider
Liu Yanjun Jayla
Role
Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Restricted Stock | -- | -- | -- |
| holding | Restricted Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option — 68,150 contracts (Direct);
Class A Common Stock — 27,326 shares (Direct);
Restricted Stock — 18,215 shares (Direct)
Footnotes (7)
- F1. On April 1, 2021, pursuant to the 2019 Equity Incentive Plan, the Reporting Person was granted the restricted stock. As of the reporting date, all of the restricted stock has fully vested, but remains subject to transfer restrictions. Such restrictions will lapse, and the shares will become transferable upon the date that is 30 months following the Issuer's initial public offering date ("IPO" date).
- F2. On January 1, 2023, pursuant to the 2019 Equity Incentive Plan, the Reporting Person was granted the restricted stock. All of the restricted stock was fully vested upon grant, but remains subject to transfer restrictions. Such restrictions will lapse, and the shares will become transferable upon the date that is 30 months following the Issuer's IPO date.
- F3. On December 31, 2023, pursuant to the 2023 Equity Incentive Plan, the Reporting Person was granted stock options to purchase a total of 36,800 shares of the Issuer's common stock. The options vest in equal annual installments over a four-year period, with the first vesting date on December 31, 2024. These options become exercisable upon vesting. Any unvested portion of the options will be forfeited upon the Reporting Person's termination of service.
- F4. On March 1, 2024, pursuant to the 2019 Equity Incentive Plan, the Reporting Person was granted stock options to purchase a total of 350 shares of the Issuer's common stock. All of the options were fully vested upon grant. The options become exercisable in installments of 30%, 30%, and 40% upon the dates that are six months, eighteen months, and thirty months, respectively, following the grant date.
- F5. On June 30, 2024, pursuant to the 2023 Equity Incentive Plan, the Reporting Person was granted stock options to purchase a total of 20,000 shares of the Issuer's common stock. As of the reporting date, all options are vested and exercisable.
- F6. On March 31, 2025, pursuant to the 2023 Equity Incentive Plan, the Reporting Person was granted stock options to purchase a total of 1,000 shares of the Issuer's common stock. All of the options were fully vested upon grant. The options become exercisable in installments of 30%, 30%, and 40% upon the dates that are six months, eighteen months, and thirty months, respectively, following the grant date.
- F7. On March 31, 2025, pursuant to the 2023 Equity Incentive Plan, the Reporting Person was granted stock options to purchase a total of 10,000 shares of the Issuer's common stock. The options vest in equal annual installments over a two-year period, with the first vesting date on March 31, 2026. The vesting will be performance-based, with vesting percentages of 0%, 50%, and 100%, respectively. These options become exercisable upon vesting. Any unvested portion of the options will be forfeited upon the Reporting Person's termination of service.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Cheche Group (CCG) Form 3 disclose about COO Liu Yanjun Jayla?
The Form 3 shows COO Liu Yanjun Jayla’s initial ownership in Cheche Group, including Class A common stock, restricted stock and several stock option grants under the 2019 and 2023 Equity Incentive Plans, with detailed grant sizes, vesting terms and expiration dates.
What stock option grants does the Cheche Group (CCG) COO hold?
The COO holds stock options granted on December 31 2023, March 1 2024, June 30 2024 and March 31 2025, covering 36,800, 350, 20,000, 1,000 and 10,000 shares of Class A common stock, all at a per-share exercise price of $0.1000.
What transfer restrictions affect Cheche Group (CCG) COO’s restricted stock holdings?
Restricted stock granted on April 1 2021 and January 1 2023 is fully vested but remains subject to transfer restrictions. These restrictions lapse, and the shares become transferable, on the date that is 30 months after Cheche Group’s initial public offering date.
Which equity incentive plans govern Cheche Group (CCG) COO’s awards?
The COO’s restricted stock grants on April 1 2021 and January 1 2023 were issued under the 2019 Equity Incentive Plan. Later stock option grants in 2023, 2024 and 2025 were made under both the 2019 Equity Incentive Plan and the 2023 Equity Incentive Plan.
Are Cheche Group (CCG) COO’s more recent option grants performance-based?
One 10,000-share option grant dated March 31 2025 includes performance-based vesting. It vests in equal annual installments over two years starting March 31 2026, with vesting percentages of 0%, 50% or 100%, and becomes exercisable only as each performance-based vesting tranche is achieved.
AI-generated analysis. How Rhea-AI works. Not financial advice.
